Blog
About

25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Incremental Cost of Conducting Population-Based Prevalence Surveys for a Neglected Tropical Disease: The Example of Trachoma in 8 National Programs

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Trachoma prevalence surveys provide the evidence base for district and community-wide implementation of the SAFE strategy, and are used to evaluate the impact of trachoma control interventions. An economic analysis was performed to estimate the cost of trachoma prevalence surveys conducted between 2006 and 2010 from 8 national trachoma control programs in Africa.

          Methodology and Findings

          Data were collected retrospectively from reports for 165 districts surveyed for trachoma prevalence using a cluster random sampling methodology in Ethiopia, Ghana, Mali, Niger, Nigeria, Sudan, Southern Sudan and The Gambia.

          The median cost per district survey was $4,784 (inter-quartile range [IQR] = $3,508–$6,650) while the median cost per cluster was $311 (IQR = $119–$393). Analysis by cost categories (personnel, transportation, supplies and other) and cost activity (training, field work, supervision and data entry) revealed that the main cost drivers were personnel and transportation during field work.

          Conclusion

          Population-based cluster random surveys are used to provide the evidence base to set objectives and determine when elimination targets have been reached for several neglected tropical diseases, including trachoma. The cost of conducting epidemiologically rigorous prevalence surveys should not be a barrier to program implementation or evaluation.

          Author Summary

          The costs of conducting population-based prevalence surveys for neglected tropical diseases such as trachoma are often cited as a reason that program managers do not conduct baseline or impact assessments when guidelines suggest they are warranted. The authors conducted a review of actual costs incurred during the implementation of 165 district level surveys in 8 national trachoma control programs to identify the median and mean costs per district and per cluster. In addition, the costs of the principal activities that are the most expensive were measured. The data show that field work is the most expensive activity for a prevalence survey, with personnel ( per diems, allowances and accommodation) and transport costs driving the total cost of the survey. These findings can be used by program managers to budget for population-based prevalence surveys that are recommended for baseline and evaluation surveys, and periodic uptake surveys for neglected tropical diseases such as trachoma.

          Related collections

          Most cited references 8

          • Record: found
          • Abstract: found
          • Article: not found

          A simple system for the assessment of trachoma and its complications.

          A simple grading system for trachoma, based on the presence or absence of five selected "key" signs, has been developed. The method was tested in the field and showed good observer agreement, the most critical point being the identification of severe cases of the disease. It is expected that the system will facilitate the assessment of trachoma and its complications by non-specialist health personnel working at the community level.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Trachoma: global magnitude of a preventable cause of blindness.

            Trachoma is the leading cause of infectious blindness worldwide. It is known to be highly correlated with poverty, limited access to healthcare services and water. In 2003, the WHO estimated that 84 million people were suffering from active trachoma, and 7.6 million were severely visually impaired or blind as a result of trachoma: this study provides an updated estimate of the global prevalence of trachoma based on the most recent information available. A literature search of recent published and unpublished surveys in the 57 endemic countries was carried out: the result of surveys that used the WHO trachoma grading system and additional information from regional and country experts served as a basis to determine the prevalence of trachoma in each country. Population-based surveys provided recent information for 42 out of 57 endemic countries. 40.6 million people are estimated to be suffering from active trachoma, and 8.2 million are estimated to have trichiasis. The current estimate of prevalence of trachoma is lower than the previous WHO estimates: this can be explained by the success in implementing control strategy, by more accurate data, as well as by socio-economic development in endemic countries.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The magnitude and cost of global blindness: an increasing problem that can be alleviated.

              To identify the potential effect on global economic productivity of successful interventions, that are planned as part of the "VISION 2020-right to sight" initiative. The initiative aims to eliminate avoidable blindness. This study used economic and epidemiologic modeling. Existing data and assumptions about blindness prevalence, national populations, gross domestic product (GDP) per capita, labor force participation, and unemployment rates were used to project the economic productivity loss associated with unaccommodated blindness. Without extra interventions, the global number of blind individuals would increase from 44 million in the year 2000 to 76 million in 2020. A successful VISION 2020 initiative would result in only 24 million blind in 2020 and lead to 429 million blind person-years avoided. A conservative estimate of the economic gain is $102 billion. The VISION 2020 initiative has the potential to increase global economic productivity.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Negl Trop Dis
                plos
                plosntds
                PLoS Neglected Tropical Diseases
                Public Library of Science (San Francisco, USA )
                1935-2727
                1935-2735
                March 2011
                8 March 2011
                : 5
                : 3
                Affiliations
                [1 ]Georgia Institute of Technology, Atlanta, Georgia, United States of America
                [2 ]The Carter Center, Atlanta, Georgia, United States of America
                [3 ]The London School of Hygiene and Tropical Medicine, London, United Kingdom
                [4 ]Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom
                University of Oklahoma Health Sciences Center, United States of America
                Author notes

                Conceived and designed the experiments: CC PME. Performed the experiments: CC. Analyzed the data: CC JDK JMN. Contributed reagents/materials/analysis tools: EMHE. Wrote the paper: CC EAC AM. Edited paper, guarantor of paper: PME.

                Article
                10-PNTD-RA-1470R4
                10.1371/journal.pntd.0000979
                3050919
                21408130
                Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
                Counts
                Pages: 6
                Categories
                Research Article
                Infectious Diseases/Neglected Tropical Diseases
                Ophthalmology

                Infectious disease & Microbiology

                Comments

                Comment on this article